With ‘Cure’ Comment, Trump Exaggerates Known Benefits of Another Covid-19 Therapy

Experts think monoclonal antibodies, like the cocktail taken by Mr. Trump, could fare better than hydroxychloroquine and convalescent plasma.

The treatment is “super promising, and all of us are excited from a theoretical perspective,” Dr. Ranney said. “But it’s just too early,” she added, to tell if theory will translate into practice.

Monoclonal antibodies are synthetic, mass-produced mimics of the molecules the human body produces in response to an infection. Some antibodies are powerful enough to block the coronavirus from infiltrating cells. Administered to people battling the coronavirus, the monoclonal antibodies could help naturally produced immune molecules fend off the virus.

Just days before Mr. Trump tested positive for the coronavirus and was admitted to the hospital, Regeneron announced a batch of preliminary results, collected from ongoing trials, via news release. They suggested Regeneron’s monoclonal antibody cocktail could tamp down the amount of virus found in the nasal cavity, and

Read More
Read More

Trump to appear on ‘Tucker Carlson Tonight’ in first on-camera interview after COVID-19 diagnosis

President Trump is scheduled to make his first on-camera interview appearance on Friday since he announced last week that he tested positive for the novel coronavirus.

The interview will take place on “Tucker Carlson Tonight” at 8 p.m. ET. Dr. Marc Siegel will conduct a medical evaluation and interview during the program.

The public has largely received information about the president’s condition from his daily tweets and updates from his medical team.

TRUMP CAN RETURN TO ‘PUBLIC ENGAGEMENTS’ THIS WEEKEND, WHITE HOUSE PHYSICIAN SAYS

President Donald Trump walks out of Walter Reed National Military Medical Center to return to the White House after receiving treatments for COVID-19, Monday, Oct. 5, 2020, in Bethesda, Md. (AP Photo/Evan Vucci)

President Donald Trump walks out of Walter Reed National Military Medical Center to return to the White House after receiving treatments for COVID-19, Monday, Oct. 5, 2020, in Bethesda, Md. (AP Photo/Evan Vucci)

During a phone interview on “Hannity” Thursday, the president said he was doing “really good,” and that he would probably be tested again for the virus on Friday.

White House physician Sean Conley 

Read More
Read More

Fox News medical contributor to conduct first Trump on-camera interview since COVID-19 diagnosis

A Fox News medical contributor will interview President TrumpDonald John TrumpBiden campaign raises over M on day of VP debate Trump chastises Whitmer for calling him ‘complicit’ in extremism associated with kidnapping scheme Trump says he hopes to hold rally Saturday despite recent COVID-19 diagnosis MORE on camera Friday night for the first time since the president tested positive for COVID-19 last week.

Marc Siegel will conduct the interview remotely from New York, with Trump participating from the White House, Fox News said.

“[Trump] will discuss his current condition as well as his experience,” Fox News said in a statement Friday.

ADVERTISEMENT

The interview will air on “Tucker CarlsonTucker CarlsonFox News Media signs three-book deal with HarperCollins in launch of publishing platform Fox News tops broadcast networks for first time in 3rd quarter Will Chis Wallace’s debate topics favor Biden over Trump? MORE Tonight” at 8 p.m.

Read More
Read More

Trump Steel Tariffs Bring Job Losses to Swing State Michigan | Top News

CHICAGO(Reuters) – President Donald Trump promised a new dawn for the struggling U.S. steel industry in 2016, and the lure of new jobs in Midwestern states including Michigan helped him eke out a surprise election win.

Four years later, Great Lakes Works – once among the state’s largest steel plants – has shut down steelmaking operations and put 1,250 workers out of a job. A year before the June layoffs, plant owner United States Steel Corp called off a plan to invest $600 million in upgrades amid deteriorating market conditions.

Trump’s strategy centered on shielding U.S. steel mills from foreign competition with a 25% tariff imposed in March 2018. He also promised to boost steel demand through major investments in roads, bridges and other infrastructure.

But higher steel prices resulting from the tariffs dented demand from the Michigan-based U.S. auto industry and other steel consumers. And the Trump administration has

Read More
Read More

Trump Appointee Is Turning Voice of America Into Partisan Outlet, Lawsuit Says

WASHINGTON — Five officials suspended from the government’s global media agency sued its chief executive and top aides on Thursday, claiming they broke the law in repeatedly seeking to turn a news service under its purview into a mouthpiece for pro-Trump propaganda.

The 84-page lawsuit asserts that Michael Pack, the chief executive of the U.S. Agency for Global Media, or his aides have interrogated journalists at the Voice of America who have censured Mr. Pack or written articles top officials believed were critical of President Trump, instilling fear across the agency.

Mr. Pack’s aide, Samuel E. Dewey, for example, began a retaliatory investigation against the Voice of America’s White House bureau chief, Steve Herman, after he signed a letter in August saying Mr. Pack risked “crippling” the news outlet.

As part of that investigation, Mr. Dewey and another aide scrutinized Mr. Herman’s “private social media activity for any hint of

Read More
Read More

As Trump hails Regeneron treatment, his administration tries to block the science it used

President Donald Trump has been celebrating the dose of experimental monoclonal antibodies he was given last Friday, saying he thinks it helped him vanquish his coronavirus infection in record time.



a sign on the side of a building: A logo sign outside of the headquarters of Regeneron Pharmaceuticals, Inc., in Tarrytown, New York on November 21, 2015. Photo by Kristoffer Tripplaar *** Please Use Credit from Credit Field ***


© Kristoffer Tripplaar/SIPA/Sipa USA/AP
A logo sign outside of the headquarters of Regeneron Pharmaceuticals, Inc., in Tarrytown, New York on November 21, 2015. Photo by Kristoffer Tripplaar *** Please Use Credit from Credit Field ***

“It was incredible the impact it had,” he said in a video he tweeted Thursday.

What he didn’t say is that the treatment was developed using technology his administration has worked for four years to ban.

It has to do with abortion politics, and the science of using human tissue to test and to make medicines. Regeneron’s therapy indirectly relied on tissue taken from an abortion.

Trump’s base, of course, is strongly against abortion rights and his administration acted quickly to reverse many Obama

Read More
Read More

Iranian government admission shows Trump right and Biden wrong on student visas | American Enterprise Institute

The Trump administration’s efforts to restrict student visas from countries designated as state sponsors of terrorism might seem like common sense, but, like everything else in an election year, it has become fodder for the partisan meatgrinder. Late last month, U.S. Immigration and Customs Enforcement published a rule change to end indefinite visas for enrolled students originating in countries where visitors often violated the terms of their visas, or countries that are state sponsors of terrorism. None of this, of course, would end the issuance of visas; rather, certain students would have to re-apply after two or four years.

Joe Biden has generally opposed any new controls on foreign students. “Across the world, people come to this country with unrelenting optimism and determination toward the future. They study here, innovate here, they make America who we are. Donald Trump doesn’t get that — we need a president who does,” Biden

Read More
Read More

Trump further targets tech-friendly work visa programs in latest immigration restrictions

The Trump administration on Tuesday outlined new rules tightening restrictions placed on guest worker visa programs, including the H-1B program favored by tech industry firms.



a man wearing a suit and tie


© Photo by Win McNamee/Getty Images


The rules tighten eligibility around foreign workers, so employers must meet more stringent criteria around the jobs they’re hiring for and how much they’re paying. That may make it harder for companies to receive H-1B visas as part of the annual lottery that awards 60,000 slots to foreign workers, not including renewals. The new rules follow a June order from President Donald Trump suspending a range of guest worker visa programs through the end of the year, with the White House citing domestic job losses during the COVID-19 pandemic as the motivator.

Loading...

Load Error

The tech and IT industries that rely on foreign talent now face more hiring restrictions

The Trump administration says the goal is to ensure companies

Read More
Read More

Ahead of election, Trump imposes new curbs on H-1B visas

The Trump administration has announced new restrictions on H-1B non-immigrant visa programme which it said is aimed at protecting American workers, restoring integrity and to better guarantee that H-1B petitions are approved only for qualified beneficiaries and petitioners, a move which is likely to affect thousands of Indian IT professionals.

The interim final rule announced by the Department of Homeland Security on Tuesday, less than four weeks ahead of the US presidential election, will narrow the definition of “specialty occupation” as Congress intended by closing the overbroad definition that allowed companies to game the system.

It will also require companies to make “real” offers to “real employees,” by closing loopholes and preventing the displacement of the American workers.

 

And finally, the new rules would enhance the department’s ability to enforce compliance through worksite inspections and monitor compliance before, during and after an H1-B petition is approved.

The H1B visa is

Read More
Read More

Trump administration’s proposed F-35 sale to UAE hits snag

The Trump administration proposal to sell the F-35, the world’s most advanced and sophisticated stealth warplane to the United Arab Emirates, the UAE, is facing turbulence.

Sen. Jim Risch, R-Idaho, the chairman of the U.S. Senate Foreign Relations Committee, has raised concerns about the proposed sale and its impact on the security of U.S. technology and its impact on Israel’s defense.

“Any potential arms sales must continue congressional consultations on meeting our obligation to retain Israel’s Qualitative Military Edge and satisfying the other requirements of the Arms Export Control Act,” the senator recently told the committee.

TRUMP TARGETS ILLICIT IRAN TRADE AHEAD OF ISRAEL-GULF NATIONS WHITE HOUSE MEETING

“It doesn’t take a rocket scientist to figure out that if Israel’s the only country in the Middle East that has F-35’s, that selling it to someone else no longer produces that qualitative military edge in the air,” said ranking member Senator

Read More
Read More